Close

FBR Capital Reiterates Bullish View on Alnylam Pharmaceuticals (ALNY) as ALN-GO1 Provides Early Human Proof-of-Concept in PH1

Go back to FBR Capital Reiterates Bullish View on Alnylam Pharmaceuticals (ALNY) as ALN-GO1 Provides Early Human Proof-of-Concept in PH1